secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2023-01-20T23:59:59+00:00
Accession:  0001213900-23-003906
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma transmits three PCT patent applications to USPTO for psilocybin delivery
--------------------------------------------------------------------------------

- Received notice of successful transmission to USPTO for three PCT patent applications.
- Applications filed July 2021 relate to CNS-homing peptides delivering anti-inflammatory therapeutics with psilocybin.
- National phase entries for these PCT applications are now at the USPTO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023003906/0001213900-23-003906-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023003906/ea171925-8k_silopharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-003906

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer